Research programme: T cell inhibitors - BioWa
Latest Information Update: 29 May 2007
At a glance
- Originator BioWa
- Class Monoclonal antibodies
- Mechanism of Action T lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma
Most Recent Events
- 28 Feb 2005 This programme is still in active development - BPN-2005
- 25 Feb 2004 Preclinical trials in Allergic asthma in USA (Parenteral)